Table 2

Mutations identified in patients with BMF

Gene affectedMutationInitial diagnosisFrequency of mutation/total patients screened
TERC C35T MDS 1/200 
TERC T100A DC 1/200 
TERC 3′ del 74 bp DC 1/200 
TERC 5′ del 316 bp DC 1/200 
TERT P704S AA, DC 2/199 
TERT Y846C AA 1/199 
TERT H876Q AA 1/199 
TERT A716V AA 1/199 
TERT C1015R AA 1/199 
DKC1 Q31E DC 1/19* 
DKC1 T66A DC/HH 1/19* 
DKC1 S304N DC/HH 1/19* 
DKC1 L317V DC 1/19* 
DKC1 A353V DC, DC 2/19* 
DKC1 A386T DC 1/19* 
Gene affectedMutationInitial diagnosisFrequency of mutation/total patients screened
TERC C35T MDS 1/200 
TERC T100A DC 1/200 
TERC 3′ del 74 bp DC 1/200 
TERC 5′ del 316 bp DC 1/200 
TERT P704S AA, DC 2/199 
TERT Y846C AA 1/199 
TERT H876Q AA 1/199 
TERT A716V AA 1/199 
TERT C1015R AA 1/199 
DKC1 Q31E DC 1/19* 
DKC1 T66A DC/HH 1/19* 
DKC1 S304N DC/HH 1/19* 
DKC1 L317V DC 1/19* 
DKC1 A353V DC, DC 2/19* 
DKC1 A386T DC 1/19* 

MDS indicates myelodysplastic syndrome; DC, dyskeratosis congenita; AA, aplastic anemia; and HH, Hoyeraal Hreidarson.

*

DKC1 gene was only analyzed in male patents with clinical signs of HH, DC, or telomere lengths less than the 1st percentile.

or Create an Account

Close Modal
Close Modal